WAUI
BSX icon

WELLINGTON-ALTUS USA INC.’s Boston Scientific BSX Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Hold
1,598
– – 0.07% 217
2026
Q1 		$68.2K Hold
1,598
– – 0.04% 291
2025
Q4 		$152K Buy
+1,598
New +$157K 0.11% 151

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s BSX Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its Boston Scientific (BSX) position steady in Q2 2026 at 1,598 shares worth $100K. The position accounts for 0.07% of the portfolio, ranked #217.

WELLINGTON-ALTUS USA INC. first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $152K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 1,598 shares of Boston Scientific worth $100K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.07% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #217 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Boston Scientific position peaked at $152K in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.